Old Web
English
Sign In
Acemap
>
authorDetail
>
Anna Affini
Anna Affini
University of Düsseldorf
Histamine H3 receptor
Receptor
Pharmacology
Monoamine oxidase B
Histamine
5
Papers
62
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Adenosine A 2A R/A 1 R Antagonists Enabling Additional H 3 R Antagonism for the Treatment of Parkinson's Disease.
2021
Journal of Medicinal Chemistry
Stefanie Hagenow
Anna Affini
Elsa Y. Pioli
Sonja Hinz
Yan Zhao
Grégory Porras
Vigneshwaran Namasivayam
Christa E. Müller
Jian-Sheng Lin
Erwan Bezard
Holger Stark
Show All
Source
Cite
Save
Citations (1)
Rasagiline derivatives combined with histamine H3 receptor properties
2019
Bioorganic & Medicinal Chemistry Letters
Kiril Lutsenko
Stefanie Hagenow
Anna Affini
David Reiner
Holger Stark
Show All
Source
Cite
Save
Citations (7)
Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson’s disease
2018
European Journal of Medicinal Chemistry
Anna Affini
Stefanie Hagenow
Aleksandra Zivkovic
José Marco Contelles
Holger Stark
Show All
Source
Cite
Save
Citations (23)
Dual MAO B and histamine H3 receptor inhibitor ST1957, a potential drug candidate for therapy of neurodegenerative diseases
2018
Stefanie Hagenow
Anna Stasiak
Anna Affini
Aleksandra Zivkovic
Wiesława Agnieszka Fogel
Holger Stark
Show All
Source
Cite
Save
Citations (0)
Multiple Targeting Approaches on Histamine H3 Receptor Antagonists
2016
Frontiers in Neuroscience
Mohammad A. Khanfar
Anna Affini
Kiril Lutsenko
Katarina Nikolic
Stefania Butini
Holger Stark
Show All
Source
Cite
Save
Citations (31)
1
map